Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Scott Oh
The CD44high Tumorigenic Subsets in Lung Cancer Biospecimens Are Enriched for Low miR-34a Expression
PLoS ONE
Multidisciplinary
Related publications
miR-34a Expression in Human Breast Cancer Is Associated With Drug Resistance
Oncotarget
Oncology
miR-497 and miR-34a Retard Lung Cancer Growth by Co-Inhibiting Cyclin E1 (CCNE1)
Oncotarget
Oncology
MicroRNA-34a (miR-34a)
Science-Business eXchange
The Low Expression of miR-451 Predicts a Worse Prognosis in Non-Small Cell Lung Cancer Cases
PLoS ONE
Multidisciplinary
Mechanism Research of miR‐34a Regulates Axl in Non‐small‐cell Lung Cancer With Gefitinib‐acquired Resistance
Thoracic Cancer
Medicine
Pulmonary
Respiratory Medicine
Oncology
ZEB1 Drives Prometastatic Actin Cytoskeletal Remodeling by Downregulating miR-34a Expression
Journal of Clinical Investigation
Medicine
Predictive Relevance of miR‑34a, miR‑224 and miR‑342 in Patients With Advanced Squamous Cell Carcinoma of the Lung Undergoing Palliative Chemotherapy
Oncology Letters
Cancer Research
Oncology
High Expression of miR-155 and miR-21 in the Recurrence or Metastasis of Non-Small Cell Lung Cancer
Oncology Letters
Cancer Research
Oncology
Figure 6: Quantitative PCR Analysis of miR-26a-5p, miR-181a-5p, miR-34a-5p, miR-93-5p, Pten, Creb, BCL-2, and Sirt1 Expression in miR-26a-5p (A), miR-181a-5p (B), miR-34a-5p (C), miR-93-5p (D) Mimic Transfected HUVECs.
